“Results of a Phase 2 Multicenter Study Evaluating the Safety and Tolerability of VP-315, an Investigational Therapy for Basal Cell Carcinoma” (2024) SKIN The Journal of Cutaneous Medicine, 8(6), p. s480. doi:10.25251/skin.8.supp.480.